Company Filing History:
1 out of 9 
1 out of 4,304 
1 out of 1 Years Active: 2007
Title: **Innovative Breakthroughs of Inventor Zhende Liu**
Introduction
Zhende Liu, an accomplished inventor based in Guangdong, China, has made significant contributions to the fields of medicine and pharmacology. With a total of two patents, his work primarily focuses on developing innovative compounds aimed at combating metabolic disorders, including type 2 diabetes and its related complications.
Latest Patents
Zhende Liu's most recent patents showcase his expertise in creating novel therapeutic agents. One of his patents, titled "Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity," details the preparation and pharmaceutical application of these derivatives. These compounds serve as selective agonists that activate peroxisome proliferator-activated receptors (PPAR), particularly the RXR/PPARalpha, RXR/PPARgamma, and RXR/PPARdelta heterodimers. This innovative approach is aimed at treating and preventing type 2 diabetes along with associated metabolic syndromes such as obesity, hypertension, and cardiovascular disorders, while also improving the side effect profile typically seen with conventional PPARgamma agonists.
His other patent, "Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity," also highlights his inventive prowess. This patent introduces novel noncyclic 1,3-dicarbonyl compounds, which function as dual agonists for RXR/PPARgamma and RXR/PPARalpha heterodimers. These innovative compounds have promising applications in treating and preventing similar metabolic disorders.
Career Highlights
Zhende Liu has gained valuable experience working with esteemed organizations, including Shenzhen Chipscreen Biosciences, Ltd. and Tsinghua University. His roles in these institutions allowed him to further develop his expertise and contribute to groundbreaking research, particularly in pharmacological innovations.
Collaborations
Throughout his career, Zhende Liu has collaborated with notable professionals in the field, including colleagues Xian-Ping Lu and Zhibin Li. These partnerships have facilitated significant advancements in his research and further reinforced his impact on metabolic health.
Conclusion
Inventor Zhende Liu stands out for his innovative work in the pharmaceutical sector, particularly in developing compounds that target critical health issues such as type 2 diabetes and metabolic syndrome. His patents reflect a commitment to enhancing therapeutic methods and improving patient outcomes, marking him as an influential figure in the realm of medical innovations.